Mitochondrial and apoptotic<i>in vitro</i>modelling of differential HIV-1 progression and antiretroviral toxicity
Constanza Morén(Bellvitge University Hospital), Glòria Garrabou(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Enric Pedrol(Hospital General de Granollers), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Francesc Cardellach(Centre for Biomedical Network Research on Rare Diseases), Mariona Guitart‐Mampel(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Ingrid González‐Casacuberta(Centre for Biomedical Network Research on Rare Diseases), Peré Domingo(Hospital de Sant Pau), Estebán Martínez(Instituto de Salud Carlos III), Òscar Miró(Hospital Clínic de Barcelona), Marc Catalán‐García(Centre for Biomedical Network Research on Rare Diseases), Joaquim Peraire(Instituto de Salud Carlos III), Josep M. Gatell, E. Tobías(Centre for Biomedical Network Research on Rare Diseases), M. Carmen Bañó(Centre for Biomedical Network Research on Rare Diseases)
Cited by 6
Related Papers
Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2020|489
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
|New England Journal of Medicine|2023|476
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Indications and practical approach to non-invasive ventilation in acute heart failure
|European Heart Journal|2017|229
Precipitating Factors and 90-Day Outcome of Acute Heart Failure: A Report from the Intercontinental GREAT Registry
|European Journal of Heart Failure|2016|149